SAN DIEGO & DORTMUND, Germany--(BUSINESS WIRE)--PROTAGEN AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmune field, and Inova Diagnostics, ...

SAN DIEGO, Jan. 3, 2018 /PRNewswire/ -- Inova Diagnostics, a world leader in autoimmune disease diagnostic systems and reagents for the clinical laboratory, is proud to announce the clearance of ...

INOVA Diagnostics Inc., a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the global launch of QUANTA Lite Calprotectin, a new FDA ...

Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, announced today that it has received 510(k) clearance by the U.S. Food and Drug ...

Aptiva addresses many health economic shortcomings in the autoimmune laboratory. Existing systems provide a limited number of analytes that do not reduce the seronegative gap found in many disease ...

The positions in the table below reflect the Inova Diagnostics's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

Protagen AG and Inova Diagnostics have signed a semi-exclusive license agreement for BICD2, a novel autoantigen and the first proprietary biomarker discovered by Protagen employing its SeroTag® ...

Inova Diagnostics this week bagged new technology developed at Hasselt University designed to identify a more sensitive collection of biomarkers for rheumatoid arthritis, once again setting its sights ...